827 related articles for article (PubMed ID: 18774375)
1. Risk stratification of patients diagnosed with gastrointestinal stromal tumor.
Joensuu H
Hum Pathol; 2008 Oct; 39(10):1411-9. PubMed ID: 18774375
[TBL] [Abstract][Full Text] [Related]
2. A modification of NIH consensus criteria to better distinguish the highly lethal subset of primary localized gastrointestinal stromal tumors: a subdivision of the original high-risk group on the basis of outcome.
Huang HY; Li CF; Huang WW; Hu TH; Lin CN; Uen YH; Hsiung CY; Lu D
Surgery; 2007 Jun; 141(6):748-56. PubMed ID: 17560251
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
4. Which is the optimal risk stratification system for surgically treated localized primary GIST? Comparison of three contemporary prognostic criteria in 171 tumors and a proposal for a modified Armed Forces Institute of Pathology risk criteria.
Goh BK; Chow PK; Yap WM; Kesavan SM; Song IC; Paul PG; Ooi BS; Chung YF; Wong WK
Ann Surg Oncol; 2008 Aug; 15(8):2153-63. PubMed ID: 18546045
[TBL] [Abstract][Full Text] [Related]
5. Surgical management and clinical outcome of gastrointestinal stromal tumor of the colon and rectum.
Chen CW; Wu CC; Hsiao CW; Fang FC; Lee TY; Che FC; Tsai WC; Jao SW
Z Gastroenterol; 2008 Aug; 46(8):760-5. PubMed ID: 18759198
[TBL] [Abstract][Full Text] [Related]
6. The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome.
Feakins RM
Histopathology; 2005 Mar; 46(3):270-9. PubMed ID: 15720412
[TBL] [Abstract][Full Text] [Related]
7. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor.
Rutkowski P; Nowecki ZI; Michej W; Debiec-Rychter M; Woźniak A; Limon J; Siedlecki J; Grzesiakowska U; Kakol M; Osuch C; Polkowski M; Głuszek S; Zurawski Z; Ruka W
Ann Surg Oncol; 2007 Jul; 14(7):2018-27. PubMed ID: 17473953
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
[TBL] [Abstract][Full Text] [Related]
9. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
[TBL] [Abstract][Full Text] [Related]
10. A nonrandom association between gastrointestinal stromal tumors and myeloid leukemia.
Miettinen M; Kraszewska E; Sobin LH; Lasota J
Cancer; 2008 Feb; 112(3):645-9. PubMed ID: 18041070
[TBL] [Abstract][Full Text] [Related]
11. Serosal penetration is an important prognostic factor for gastrointestinal stromal tumors.
Vallböhmer D; Marcus HE; Baldus SE; Brabender J; Drebber U; Metzger R; Hölscher AH; Schneider PM
Oncol Rep; 2008 Oct; 20(4):779-83. PubMed ID: 18813818
[TBL] [Abstract][Full Text] [Related]
12. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of four histopathological classification systems to discriminate benign and malignant behaviour in gastrointestinal stromal tumors.
Vallböhmer D; Marcus HE; Baldus SE; Brabender J; Lurje G; Drebber U; Metzger R; Hölscher AH; Schneider PM
Anticancer Res; 2008; 28(1B):367-72. PubMed ID: 18383871
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal stromal tumors (GISTs): analysis of 20 cases.
Bölükbasi H; Nazli O; Tansug T; Bozdag AD; Isgiider AS; Yaman I; Haciyanli M; Genc H
Hepatogastroenterology; 2006; 53(69):385-8. PubMed ID: 16795978
[TBL] [Abstract][Full Text] [Related]
15. Surgical outcomes and immunohistochemical features for gastrointestinal stromal tumors (GISTS) of the stomach: with special reference to prognostic factors.
Park SS; Ryu JS; Oh SY; Kim WB; Lee JH; Chae YS; Kim SJ; Kim CS; Mok YJ
Hepatogastroenterology; 2007; 54(77):1454-7. PubMed ID: 17708275
[TBL] [Abstract][Full Text] [Related]
16. Tumor size is a major determinant of recurrence in patients with resectable gastrointestinal stromal tumor.
Hsu KH; Yang TM; Shan YS; Lin PW
Am J Surg; 2007 Aug; 194(2):148-52. PubMed ID: 17618793
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic resection for gastrointestinal stromal tumors of the stomach.
Nakamori M; Iwahashi M; Nakamura M; Tabuse K; Mori K; Taniguchi K; Aoki Y; Yamaue H
Am J Surg; 2008 Sep; 196(3):425-9. PubMed ID: 18466871
[TBL] [Abstract][Full Text] [Related]
18. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal stromal tumors: a 19 year experience.
Rabin I; Chikman B; Lavy R; Sandbank J; Maklakovsky M; Gold-Deutch R; Halpren Z; Wassermann I; Halevy A
Isr Med Assoc J; 2009 Feb; 11(2):98-102. PubMed ID: 19432038
[TBL] [Abstract][Full Text] [Related]
20. [Gastrointestinal stromal tumors - a retrospective study of 43 cases].
Folgado Alberto S; Sánchez P; Oliveira M; Cuesta L; Gomes F; Figueiredo A; Pinheiro N; Ramos de Deus J
Rev Esp Enferm Dig; 2008 Nov; 100(11):696-700. PubMed ID: 19159173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]